Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-14-000633

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 14, 2014 15.19M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $170.9K
Stockholders Equity Q3 2014 · Dec 31, 2013 −$184.05K
Current Liabilities Q3 2014 · Sep 30, 2014 $199.4K
Current Liabilities Q3 2014 · Dec 31, 2013 $191.24K
Total Liabilities Q3 2014 · Sep 30, 2014 $225.4K
Total Liabilities Q3 2014 · Dec 31, 2013 $207.24K
Current Assets Q3 2014 · Sep 30, 2014 $386.7K
Current Assets Q3 2014 · Dec 31, 2013 $18.99K
Total Assets Q3 2014 · Sep 30, 2014 $396.3K
Total Assets Q3 2014 · Dec 31, 2013 $23.2K
Shares Diluted Q3 2014 · Sep 30, 2013 13.87M sh
Shares Diluted Q3 2014 · Sep 30, 2013 13.77M sh
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$115.74K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $2.5K
Cash And Equivalents Q3 2014 · Dec 31, 2012 $1.04K
Sga Expense Q3 2014 · Sep 30, 2013 $71.95K
Sga Expense Q3 2014 · Sep 30, 2013 $268.32K
Rd Expense Q3 2014 · Sep 30, 2013 $13.92K
Rd Expense Q3 2014 · Sep 30, 2013 $25.68K
Net Income Q3 2014 · Sep 30, 2013 −$88.14K
Net Income Q3 2014 · Sep 30, 2013 −$301.24K
Operating Income Q3 2014 · Sep 30, 2013 −$87K
Operating Income Q3 2014 · Sep 30, 2013 −$298.05K